Russell Frank Company’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Russell Frank Company’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-385,077	Closed	-$16.6M	–	3124
2015 Q3	$16.6M	Sell	385,077 -2,552	-0.7%	-$108K	0.03%	641
2015 Q2	$16.4M	Sell	387,629 -157,058	-29%	-$6.62M	0.03%	723
2015 Q1	$21.1M	Buy	544,687 +42,198	+8%	+$1.63M	0.04%	544
2014 Q4	$17M	Buy	502,489 +28,099	+6%	+$992K	0.03%	638
2014 Q3	$16.6M	Sell	474,390 -534,951	-53%	-$18.3M	0.03%	640
2014 Q2	$33.2M	Buy	1,009,341 +643,137	+176%	+$22M	0.06%	367
2014 Q1	$12.7M	Sell	366,204 -30,239	-8%	-$1.11M	0.02%	751
2013 Q4	$14.1M	Buy	396,443 +169,204	+74%	+$5.34M	0.03%	695
2013 Q3	$6.27M	Buy	227,239 +84,539	+59%	+$2M	0.01%	1170
2013 Q2	$3M	Buy	+142,700	New	+$2.79M	0.01%	1544

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Russell Frank Company's WX Position: Q4 2015 in Review

Russell Frank Company sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 385,077 shares — an estimated $16.6M sold.

Russell Frank Company first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $33.2M in Q2 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Russell Frank Company reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Russell Frank Company sold 385,077 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $16.6M.
Russell Frank Company first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Russell Frank Company's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $33.2M in Q2 2014.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.